← Back to headlines
ImmunityBio Stock Falls After FDA Warning on Anktiva Ad and Podcast
ImmunityBio's stock declined after the FDA issued a warning regarding an advertisement and podcast related to its drug Anktiva.
24 Mar, 14:08 — 24 Mar, 14:08
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
Bulgaria Issues 12,000 Permits for Foreign Tourism Workers in Three Months
14m ago